Kiniksa Pharmaceuticals International, plc Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, conversion of convertible securities for the quarter ending 2018-12-31 was $0.00.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, conversion of convertible securities for the quarter ending 2018-09-30 was $0.00.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, conversion of convertible securities for the quarter ending 2018-06-30 was $310.59M.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, conversion of convertible securities for fiscal 2018 was $310.59M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $310.59M 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | |
| 2018-06-30 | $310.59M 10-Q · filed 2019-11-05 |